Agenus (AGEN) Tops Q1 EPS by 41c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. BAC
4. DRS
5. GS
6. AVAV
7. ACI
8. UNH
9. ORCL
10. LQDA

Go back to Agenus (AGEN) Tops Q1 EPS by 41c, Revenues Beat

Agenus Reports First Quarter 2019 Financial Results and Provides Corporate Update

May 9, 2019 7:30 AM EDT

LEXINGTON, Mass., May 9, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, provided corporate updates and reported financial results for the first quarter of 2019.

"2019 is off to a strong start. We have made significant progress towards our efforts to bring transformative treatments... More